Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-027585

BIOLASE, INC · BIOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Harold C Flynn Jr.
Officer — President and CEO · Director
Period of report
Apr 18, 2017
Accepted (ET)
Apr 19, 2017 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811240

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series D Participating Convertible Preferred StockF1,F3,F4,F2—Apr 18, 2017P307A——Common Stock30,700307I
Warrants (right to buy)F1,F3,F4$1.80Apr 18, 2017P14,945AOct 18, 2017Apr 18, 2022Common Stock14,94514,945I

Explanation of responses